ZIM Laboratories Q1 Results
- BSE: 541400
- NSE: ZIMLAB
- ISIN: INE518E01015
- Sector: Biotechnology & Drugs
BSE
139.95
3.30 (2.41%)
3.30 (2.41%)Volume9.47 K
Updated: Fri 11 Sep, 2026 | 15:29:23
NSE
139.002.57 (1.88%)
2.57 (1.88%)Volume1.19 L
Updated: Fri 11 Sep, 2026 | 15:29:54
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
- Total Income₹94.18 Cr.(31.25%)
- Operating Profit₹-2.92 Cr.(383.12%)
- Profit After Tax₹-4.02 Cr.(114.24%)
- Operating Margin-3.10%(268.10%)
Note: Comparison is on YoY basis
Quarterly - ZIM Laboratories Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 26 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 97.10 | 103.18 | -5.90% | 78.73 | 34.19% |
| Depreciation/ Amortization | 5.37 | 5.10 | 5.28% | 4.94 | 10.46% |
| Operating Income | -2.92 | 2.09 | 0.00% | 3.09 | 383.12% |
| Net Income | -4.02 | 3.74 | 0.00% | 0.90 | 114.24% |
| Other Operating Expenses Total | 33.08 | 33.56 | -1.45% | 23.05 | 44.60% |
| Net Income Before Taxes | -5.57 | 4.94 | 0.00% | 1.23 | 129.15% |
| Total Revenue | 94.18 | 105.27 | -10.54% | 81.82 | 31.25% |
| Selling/ General/ Admin Expenses Total | 19.18 | 17.39 | 10.31% | 14.51 | 31.28% |
| Diluted Normalized EPS | -0.75 | 0.55 | 0.00% | 0.18 | 97.37% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.